Condition: Prostate Cancer Screening · Sponsor: University of Alberta
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
This description comes directly from the study's public registry record.
Stacey Broomfield, PhD · +1-780-407-5800 · sbroomfi@ualberta.ca
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles (UCLA) | Los Angeles, California, United States | Not Yet Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Not Yet Recruiting |
| University of Alberta | Edmonton, Alberta, Canada | Active Not Recruiting |
| University of British Columbia | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
| CIUSSS du Nord-de-l'Île-de-Montréal | Montréal, Quebec, Canada | Not Yet Recruiting |
| CH de Martigues | Martigues, France | Recruiting |
| Vestfold Hospital Trust | Tønsberg, Norway | Recruiting |
| Urologia Clinica Bilbao | Bilbao, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06626022